目的 探讨大剂量丙种球蛋白冲击治疗腹型过敏性紫癜（HSP）的疗效。方法 33 例腹型HSP患儿随机分为地塞米松组（15 例）和丙种球蛋白组（18 例）。地塞米松组患儿采用地塞米松和常规治疗方法进行治疗；丙种球蛋白组患儿在常规治疗基础上，给予大剂量丙种球蛋白冲击治疗。观察两组患儿临床疗效和复发率。结果 丙种球蛋白组患儿皮疹开始和完全消退时间、腹痛缓解和血便消失时间明显短于地塞米松组（P < 0.05），但呕吐缓解时间及住院时间与地塞米松组差异无统计学意义（P > 0.05）；丙种球蛋白组患儿有效率（95%）明显高于地塞米松组（65%），差异有统计学意义（P < 0.05）；且其6 个月内复发率（5.6%）明显低于对照组（33.3%），P < 0.05。结论 大剂量丙种球蛋白冲击治疗腹型HSP 症状缓解快、有效率高、复发率低。
Abstract
Objective To study the clinical effect of high-dose gamma globulin pulse therapy for abdominal Henoch-Schönlein purpura (HSP). Methods Thirty-three children with abdominal HSP were randomly assigned to dexamethasone group (15 children) and gamma globulin group (18 children). The children in the dexamethasone group were treated with dexamethasone and conventional treatment, and those in the gamma globulin group were treated with high-dose gamma globulin pulse therapy in addition to the conventional treatment. Clinical outcome and recurrence rate were observed in both groups. Results Compared with the dexamethasone group, the gamma globulin group had a significantly shorter onset time of rash, a significantly shorter time to complete regression of rash, a significantly shorter time to abdominal pain remission, and a significantly shorter time to disappearance of bloody stool, as well as comparable time to vomiting remission and length of hospital stay. The gamma globulin group had a significantly higher response rate than the dexamethasone group (95% vs 65%; P < 0.05) and a significantly lower recurrence rate within 6 months than the dexamethasone group (5.6% vs 33.3%; P < 0.05). Conclusions High-dose gamma globulin pulse therapy has a marked clinical effect in the treatment of abdominal HSP. It is safe and reliable and has a low recurrence rate, and therefore, it holds promise for clinical application.
关键词
过敏性紫癜 /
丙种球蛋白 /
地塞米松 /
儿童
Key words
Henoch-Schö /
nlein purpura /
Gamma globulin /
Dexamethasone /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 何晓琥. 过敏性紫癜[M]//胡亚美, 江载芳. 诸福棠实用儿科 学上册. 第7 版. 北京: 人民卫生出版社, 2002: 688-690.
[2] 周建峰, 易军. 过敏性紫癜的腹内并发症分析[J]. 广东医学, 2010, 31(6): 758-760.
[3] 张伟东. 西咪替丁与丙种球蛋白联合治疗小儿过敏性紫癜的 临床效果[J]. 中国实用医药, 2013, 8(29): 158-159.
[4] 胡海玉, 鹿玲. 过敏性紫癜患儿复发与反复的危险因素分析[J]. 实用儿科临床杂志, 2012, 27(21): 1663-1665.
[5] 刘丽君, 于静, 李宇宁. 儿童过敏性紫癜325 例回顾性分析[J]. 中国当代儿科杂志, 2015, 17(10): 1079-1083.
[6] Lauk KK, Suzuki H, Novak J, et al. Pathogenesis of Henoch-Schönlein purpura nephritis[J]. Pediatr Nephrol, 2010, 25(1): 19-26.
[7] Kawasaki Y, Ono A, Ohara S, et al. Henoch-Schönlein purpura nephritis in childhood: pathogenesis, prognostic factors and treatment[J]. Fukushima J Med Sci, 2013, 59(1): 15-26.
[8] 娄俊丽, 黄永坤, 刘梅, 等. 住院8 天过敏性紫癜患儿肠道 菌群的变化研究[J]. 中国微生态学杂志, 2009, 21(5): 410-414.
[9] 邵荣昌, 邹翠容. 儿童腹型过敏性紫癜80 例临床特点分析[J]. 中国中西医结合儿科学, 2012, 4(4): 363-364.
[10] 中华医学会儿科学分会免疫学组, 《中华儿科杂志》编辑 委员会. 儿童过敏性紫癜循证诊疗建议[J]. 中华儿科杂志, 2013, 51(7): 502-507.
[11] 王俊青, 刘铁民, 刘江平. 静脉注射丙种球蛋白治疗儿童过 敏性紫癜疗效观察[J]. 中国误诊学杂志, 2011, 11(1): 48.
[12] Fagbemi AA, Torrente F, Hilson AJ, et a1. Massive gastrointestinal haemorrhage in isolated intestinal Henoch-Schonlein purpura with response to intravenous immunoglobulin infusion[J]. Eur J Pediatr, 2007, 166(9): 915-919.
[13] 王兰英, 厉红, 岳爱红. 丙种球蛋白治疗重症过敏性紫癜的 临床效果分析[J]. 中国误诊学杂志, 2012, 12(16): 4277-4278.
[14] 张苗苗, 鹿玲, 胡波, 等. 糖皮质激素治疗儿童过敏性紫癜 消化道出血88 例疗效观察[J]. 中国实用儿科杂志, 2011, 26(1): 53-54.
[15] 范存杰, 丁慧敏, 李作芬. 人血丙种球蛋白治疗过敏性紫癜 并急性胰腺炎4 例报告[J]. 山东医药, 2013, 53(25): 104-105.
PDF(1237 KB)
